Skip to main content

CORRECTION article

Front. Oncol., 18 April 2024
Sec. Hematologic Malignancies
Volume 14 - 2024 | https://doi.org/10.3389/fonc.2024.1397607

Corrigendum: Determining the predictive impact of donor parity on the outcomes of human leukocyte antigen matched hematopoietic stem cell transplants: a retrospective, single-center study

This article is a correction to:

  1. Determining the predictive impact of donor parity on the outcomes of human leukocyte antigen matched hematopoietic stem cell transplants: a retrospective, single-center study

    1. Read original article
Mojtaba Azari,Mojtaba Azari1,2Maryam Barkhordar,*Maryam Barkhordar1,2*Tanaz Bahri,*Tanaz Bahri1,2*Soroush Rad,Soroush Rad2,3Hosein Kamranzadeh Fumani,Hosein Kamranzadeh Fumani2,4Seied Asadollah Mousavi,Seied Asadollah Mousavi1,2Sahar Tavakoli Shiraji,Sahar Tavakoli Shiraji2,4Morteza Azari,Morteza Azari1,2Parisa Shafaroudi,Parisa Shafaroudi1,2Mohammad Vaezi,Mohammad Vaezi2,3
  • 1Cell Therapy and Hematopoietic Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran
  • 2Research Institute for Oncology, Hematology, and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran
  • 3Hematology, Oncology and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran
  • 4Hematologic Malignancies Research Center, Tehran University of Medical Science, Tehran, Iran

A Corrigendum on
Determining the predictive impact of donor parity on the outcomes of human leukocyte antigen matched hematopoietic stem cell transplants: a retrospective, single-center study

by Azari M, Barkhordar M, Bahri T, Rad S, Kamranzadeh Fumani H, Mousavi SA, Tavakoli Shiraji S, Azari M, Shafaroudi P and Vaezi M (2024) Determining the predictive impact of donor parity on the outcomes of human leukocyte antigen matched hematopoietic stem cell transplants: a retrospective, single-center study. Front. Oncol. 14:1339605. doi: 10.3389/fonc.2024.1339605

In the published article, there was an error in Table 1 as published. In Table 1, Characteristic column, Primary disease classification section (4th row, 2nd column), “AML” and “ALL” have been miswritten interchangeably. The corrected Table 1 and its caption appear below.

Table 1
www.frontiersin.org

Table 1 Baseline characteristics of donors and recipients.

In the published article, there were some errors in the Text of Abstract, Methods and Materials, and Results section. In the final manuscript we updated the Tables and Figures according to our final analysis. However, in the text of the manuscript in some places (mainly Multivariable Cox regression analyses for the outcomes in the Results section) we did not update the text according to our final Analysis, Tables, and Figures.

A correction has been made to Abstract section, Results subsection. This sentence previously stated:

“188 (17.04%) had…”

The corrected sentence appears below:

“188 (17%) had…”

A correction has been made to Methods and Materials section, Outcomes and definitions subsection, first paragraph.

This sentence previously stated: “3-year extensive cGVHD”

The corrected sentence appears below:

“1-year extensive cGVHD”

A correction has been made to Results section, first paragraph, line 2. This sentence previously stated: “188 (17.04%) of these patients…”

The corrected sentence appears below:

“188 (17%) of these patients…”

A correction has been made to Results section, third paragraph. This sentence previously stated: “(HR= 1.48, P= 0.02)”

The corrected sentence appears below:

“(HR= 1.53, P= 0.03)”

A correction has been made to Results section, third paragraph. This sentence previously stated: “(HR= 4.14, P= 0.00)”

The corrected sentence appears below:

“(HR= 3.90, P= 0.00)”

A correction has been made to Results section, third paragraph. This sentence previously stated: “(HR= 4.46, P= 0.00)”

The corrected sentence appears below:

“(HR= 4.62, P= 0.00)”

A correction has been made to Results section, fourth paragraph. This sentence previously stated: “Additional factors associated with higher RI in univariate analysis were recipient age and sex (male vs. female), as well as disease status of second complete remission and above (≥ CR2) before transplant.”

The corrected sentence appears below:

“Additional factors associated with higher RI in univariate analysis were recipient age and sex (male vs. female), as well as primary disease of AML and disease status of second complete remission and above (≥ CR2) before transplant.”

A correction has been made to Results section, fourth paragraph. This sentence previously stated: “(HR= 1.38, P= 0.01 and HR= 1.87, P= 0.00, respectively)”

The corrected sentence appears below:

“(HR= 1.38, P= 0.01 and HR= 1.86, P= 0.00, respectively)”

A correction has been made to Results section, fourth paragraph. This sentence previously stated: “(HR= 0.57, P= 0.00 and HR= 0.61, P= 0.02, respectively)”

The corrected sentence appears below:

“(HR= 0.61, P= 0.02 and HR= 0.58, P= 0.00, respectively)”

A correction has been made to Results section, fifth paragraph. This sentence previously stated: “(HR= 0.81, P= 0.01)”

The corrected sentence appears below:

“(HR= 0.83, P= 0.02)”

A correction has been made to Results section, fifth paragraph. This sentence previously stated: “(HR= 1.25, P= 0.01 and HR= 2.49, P= 0.00, respectively)”

The corrected sentence appears below:

“(HR= 1.30, P= 0.00 and HR= 2.26, P= 0.00, respectively)”

A correction has been made to Results section, sixth paragraph. This sentence previously stated: “(HR= 0.63, P= 0.00)”

The corrected sentence appears below:

“(HR= 0.64, P= 0.00)”

A correction has been made to Results section, sixth paragraph. This sentence previously stated: “(HR= 1.44 and HR= 1.61, respectively)”

The corrected sentence appears below:

“(HR= 1.40 and HR= 1.59, respectively)”

As published, there were errors in the Discussion section. As the results obtained by Kumar et al. may be misinterpreted by us, we have deleted reference 21 and its results from the mentioned parts in our Discussion section of published article. A correction has been made to the Discussion section, third paragraph. This sentence previously stated:

“Przepiorka et al. (17) and Kumar et al. (21) observed that the gestation history of the donor did not affect the hazard for grade II-IV aGVHD incidence in recipients of HLA-matched related donors.”

The corrected sentence appears below:

“Przepiorka et al. (17) observed that the gestation history of the donor did not affect the hazard for grade II-IV aGVHD incidence in recipients of HLA-matched related donors.”

A correction has been made to the Discussion section, paragraph 4. The sentence previously stated: “The analysis by Loren et al. (2) and Kumar et al. (21) also did not find any effect of donor parity on OS among the patients who underwent the HSCT from HLA-identical siblings in the multivariate model fitted.”

The corrected sentence appears below:

“The analysis by Loren et al. (2) also did not find any effect of donor parity on OS among the patients who underwent the HSCT from HLA-identical siblings in the multivariate model fitted.”

These errors do not change the scientific conclusions of the article in any way.

The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: graft-versus-host disease (GVHD), hematopoietic stem cell transplantation (HSCT), donor parity, overall survival, relapse incidence

Citation: Azari M, Barkhordar M, Bahri T, Rad S, Kamranzadeh Fumani H, Mousavi SA, Tavakoli Shiraji S, Azari M, Shafaroudi P and Vaezi M (2024) Corrigendum: Determining the predictive impact of donor parity on the outcomes of human leukocyte antigen matched hematopoietic stem cell transplants: a retrospective, single-center study. Front. Oncol. 14:1397607. doi: 10.3389/fonc.2024.1397607

Received: 07 March 2024; Accepted: 26 March 2024;
Published: 18 April 2024.

Edited and Reviewed by:

Salvatore Leotta, Independent Researcher, Catania, Italy

Copyright © 2024 Azari, Barkhordar, Bahri, Rad, Kamranzadeh Fumani, Mousavi, Tavakoli Shiraji, Azari, Shafaroudi and Vaezi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Maryam Barkhordar, barkhordarm.n@gmail.com; maryambarkhordar2023@gmail.com; Tanaz Bahri, tanaz.bahri@gmail.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.